Novel quantification method for psilocin in brain tissues using liquid chromatography-tandem mass spectrometry
lower limit of quantification (LLOQ) using merely a protein precipitation step. In addition, the method met bioanalytical validation criteria for selectivity, accuracy, and precision, enabling reliable quantification in mouse brain tissue. Comparison of psilocybin with a psilocin-psilocybin co-crystal formulation revealed no sex- or brain region-dependent differences in brain psilocin concentrations. Psilocybin-treated mice had higher brain psilocin concentrations at 10 min than co-crystal-treated mice. Co-crystal administration appeared to yield more sustained brain psilocin concentrations, although this difference was not statistically significant compared to the psilocybin group. Under the same experimental conditions, 4-HIAA was not detected, consistent with limited brain accumulation and rapid clearance within the sampled window.
Authors
- Deborah L. Michel (ORCID: https://orcid.org/0000-0001-5161-8677)
- Anas El‐Aneed (ORCID: https://orcid.org/0000-0003-1060-3609)
- Amir Khajavinia (ORCID: https://orcid.org/0000-0002-1170-9213)
- Robert Laprairie (ORCID: https://orcid.org/0000-0002-9994-433X)
- Jordan Reekie
Institutions
- University of Saskatchewan (CA)
Publication Details
- Journal
- Analytical Methods
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1039/d6ay01614f
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Saskatchewan
- Natural Sciences and Engineering Research Council of Canada